MEBO Group Advances Healthcare Innovation at APEC 2024 Latin American Forum
On October 17, 2024, MEBO Group, in collaboration with the International Society of Regenerative Medicine and Wound Repair, successfully hosted the "International Regenerative Medicine and Wound Care Symposium – Latin American Forum" in Lima, Peru. This pivotal event marked the launch of the "Wave of Restoration in Latin America," attracting over 150 medical professionals from public and private healthcare institutions across Lima.
Promoting Global Healthcare Collaboration
Kevin Xu, Chairman of MEBO Group and the APEC 2023 Host Committee, emphasized the importance of global cooperation in medical technology. His vision of sharing innovative healthcare solutions across APEC member nations was brought to life during the forum. This initiative sought to expand the use of regenerative medical technologies throughout Latin America, fostering collaboration and knowledge exchange.
Innovative Solutions in Wound Care
Keynote speakers, including Ariel Miranda, incoming President of the International Burn Society, and Jose Young, General Manager of Discontinental, highlighted MEBO’s technological contributions to the field of wound care. Medical professionals shared real-world success stories, such as Dr. Carlos Marquez from Ecuador, who discussed using regenerative medicine to treat pressure ulcers, and Dr. Victor Coahila from Peru, who presented on diabetic foot treatment advancements.
APEC Dialogue: Focusing on Pediatric Wound Care
The forum also included discussions on pediatric wound management, where Xu Weiwei, Director of the China Office of the ISRMWR, shared insights on global pediatric wound data and cutting-edge treatment methods. The event reinforced MEBO’s commitment to healthcare development within the APEC region, while providing new opportunities for international medical collaboration.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.
stay informed. connect with us.
